DSGN - Design Therapeutics, Inc.
NEXT EARNINGS:
Mar 9, 2026
(in 12 days)
EPS Est: $-0.37
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$15.67
DETAILS
HIGH:
$18.00
LOW:
$14.00
MEDIAN:
$15.00
CONSENSUS:
$15.67
UPSIDE:
47.83%
Market Cap:
603.82M
Volume:
179,038
Avg Volume:
353,361
52 Week Range:
2.6-10.97
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.64
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
56
IPO Date:
2021-03-29
EPS (TTM):
-0.88
P/E Ratio:
-7.04
Revenue (TTM):
N/A
Total Assets:
252.09M
Total Debt:
2.33M
Cash & Equiv:
22.56M
Rev Growth (5Y):
-100.0%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-20.4%
Debt/Equity:
0.01
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-05 | $-0.30 | $-0.34 | +11.8% | — | — | — |
| 2025-08-07 | $-0.34 | $-0.32 | -6.3% | — | — | — |
| 2025-05-07 | $-0.31 | $-0.28 | -10.7% | — | — | — |
| 2025-03-10 | $-0.24 | $-0.28 | +14.3% | — | — | — |
| 2024-11-07 | $-0.23 | $-0.26 | +11.5% | — | — | — |
| 2024-08-05 | $-0.21 | $-0.25 | +16.0% | — | — | — |
| 2024-05-08 | $-0.20 | $-0.28 | +28.6% | — | — | — |
| 2024-03-19 | $-0.21 | $-0.32 | +34.4% | $838000 | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 834 |
| Net Income | (49.59M) | (66.86M) | (63.31M) | (35.53M) | (8.28M) | (2.05M) |
| EPS | -0.88 | -1.19 | -1.14 | -0.77 | -0.30 | -0.08 |
| Total Assets | 252.09M | 289.64M | 341.14M | 390.56M | 36.52M | 90,000 |
| Total Debt | 2.33M | 3.05M | 3.69M | 3.63M | 0 | 695,000 |
| Cash & Equivalents | 22.56M | 21.20M | 26.50M | 298.57M | 2.38M | 77,000 |
| Operating Cash Flow | (43.10M) | (58.56M) | (51.32M) | (29.38M) | (8.67M) | (139,000) |
| Free Cash Flow | (43.45M) | (58.82M) | (52.23M) | (30.91M) | (8.74M) | (139,000) |
| FCF per Share | -0.77 | -1.05 | -0.94 | -0.67 | -0.32 | -0.01 |
| Book Value | 242.10M | 277.69M | 327.31M | 382.13M | (11.31M) | (3.64M) |
| Cash & ST Investments | 245.48M | 281.80M | 330.39M | 384.06M | 36.09M | 77,000 |
| ROC Equity | -0.20 | -0.24 | -0.19 | -0.09 | N/A | N/A |